A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the secret to staving off Alzheimer’s, too.

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Music and Memory” examines how music can reduce agitation in people with living with Alzheimer’s and Parkinson’s.

A new study has found that regular use of certain types of commonly-prescribed drugs can increase the risk of dementia in ...

Too often as patients age, doctors pile on prescriptions. The practice, known as polypharmacy, can be dangerous at any age but is particularly hazardous for elderly people, from raising the risk of ...

In an exclusive chat to Express.co.uk, Dr John Abroon – a board-certified primary care physician – detailed the early ...

We really think of it as hopefully being a key new tool in forecasting and predicting risk for diseases, especially Alzheimer ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...